AVITA CARE SOLUTIONS
LIVE

Serial Number

97981610

Owner

Avita Drugs, LLC

Attorney

Mary Mazzello

First Use Date

Jan 9, 2023

Filing Date

Feb 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AVITA CARE SOLUTIONS Trademark

Serial Number: 97981610

AVITA CARE SOLUTIONS is a trademark filed by Avita Drugs, LLC on February 2, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Avita Drugs, LLC (25 trademarks)

Baton Rouge, LA 70808

Entity Type: 16

Trademark Details

Filing Date

February 2, 2023

Registration Date

Not Registered

First Use Anywhere

January 9, 2023

First Use in Commerce

January 9, 2023

Published for Opposition

September 5, 2023

Goods & Services

Patient medication care management and medication adherence services, namely, counseling patients regarding their medications, adherence to medication regimens, medication side-effects, allergic sensitivity, drug interactions, or other issues related to medication tolerance, alternate medication brands or generics, dosage or manner of taking medications; coordinating and implementing information and instructions regarding patients' medication regimen and adherence thereto, medication needs and issues, consideration of generic or alternative medications, between and among patients, doctors, care-givers and insurance; coordinating patient medication care management information and facilitating adherence to medication regimens, between and among patients, doctors, care-givers and insurance; dispensing medication under the federal 340B prescription drug discount program; administration and management of third party use of the federal 340B prescription drug discount program, namely, medication services in the nature of administration of medication medicating to patients and prescription refill reminder services; primary care medical services for people with HIV and the LGBTQ+ community

Prescription delivery services, administration and management of third party use of the federal 340B prescription drug discount program, namely, medication delivery services, and delivery and packing of goods for transport purposes pursuant to compliance regulations

Pharmacy services, namely, coordinating filling and refilling prescriptions, generating reports to patients, prescribers, and care givers regarding prescriptions, and assisting with pharmaceutical drug billing; retail pharmacy services; pharmaceutical cost management advisory and consulting services and drug utilization review advisory and consulting services, namely, enhancing access to low-cost pharmaceuticals for the medically underserved and supporting not-for-profit hospitals and health centers in administering and maximizing the use of the federal 340B prescription drug discount program to reduce pharmaceutical costs and improve the health status of their patients; administration and management of third party use of the federal 340B prescription drug discount program, namely, assisting with registration, reporting, business auditing, coordination and assignment of benefits, medication inventory management; pharmacy discount card services, namely, administration of a discount programs for enabling participants to obtain discounts on pharmaceutical goods through the use of a discount membership card; retail pharmacy services, namely, 340B contract pharmacy services

Facilitating and coordinating insurance authorization for prescriptions between and among patients, doctors, care-givers and insurance, and communicating with patients regarding prescription cost and insurance coverage of prescription drugs; administration and management of third party use of the federal 340B prescription drug discount program, namely, bill payment services and debt collections services

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Aug 26, 2026 SUPC
DIVISIONAL PROCESSING COMPLETE
Aug 26, 2026 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2026 AITU
USE AMENDMENT FILED
Mar 27, 2026 IUAF
DIVISIONAL REQUEST RECEIVED
Mar 27, 2026 DRRR
TEAS STATEMENT OF USE RECEIVED
Mar 27, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Mar 27, 2026 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 9, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 8, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 9, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 8, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 9, 2024 NOAM
NEW NOA TO ISSUE
Feb 28, 2024 NEWN
NOTICE OF ALLOWANCE CANCELLED
Feb 28, 2024 IUCN
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 21, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 2024 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 14, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 29, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 27, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 27, 2023 CNEA
ASSIGNED TO EXAMINER
Jul 24, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 22, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2023 NWOS
NEW APPLICATION ENTERED
Feb 7, 2023 NWAP